Canaccord Reiterates Buy Rating on Bioventus Inc (BVS)

June 16, 2026 6:37 AM

Canaccord analyst Caitlin Cronin reiterated a Buy rating and $15.00 price target on Bioventus Inc (NASDAQ: BVS).The analyst commented: "We ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found